Sunday, November 5, 2017
- 9:00AM-11:00AM
-
Abstract Number: 811
The Presence of Giant Cells in the Temporal Artery Biopsy Is Associated with Reduced Risk of Future Large Vessel Involvement in Patients with Biopsy-Proven Giant Cell Arteritis
Vasculitis Poster I: Large Vessel Vasculitis- 9:00AM-11:00AM
-
Abstract Number: 72
The Presence of IgM Rheumatoid Factor Impede Immunodetection of Tnfa on Circulating Extracellular Vesicles Obtained from Rheumatoid Arthritis Patients
Cytokines, Mediators, Cell-Cell Adhesion, Cell Trafficking and Angiogenesis Poster I: The Variable World of Intercellular Signalling- 9:00AM-11:00AM
-
Abstract Number: 288
The Rheumatoid Arthritis Susceptibility Gene C5orf30 Is an Immunomodulator in Macrophages
Innate Immunity and Rheumatic Disease Poster I- 9:00AM-11:00AM
-
Abstract Number: 273
The Risk Factors of Developing Adult T Cell Leukemia (ATL) in Human T Cell Leukemia Virus Type 1 (HTLV-1) Positive Patients with Rheumatoid Arthritis in Endemic Area, Japan; A Retrospective Cohort Study
Infection-related Rheumatic Disease Poster- 9:00AM-11:00AM
-
Abstract Number: 393
The Role of Follicular Helper 17 T Cells in Glucose-6-Phosphate Isomerase Induced Arthritis
Rheumatoid Arthritis – Animal Models Poster I- 9:00AM-11:00AM
-
Abstract Number: 506
The Selective JAK1 Inhibitor Upadacitinib Has No Effect on Pharmacokinetics of the Hormonal Contraceptives Levonorgestrel and Ethinylestradiol
Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy Poster I: Comorbidities and Adverse Events; Efficacy and Safety of Small Molecules- 9:00AM-11:00AM
-
Abstract Number: 453
The Therapy with Tocilizumab Is Not Associated with Periarticular Demineralisation and Finger Joint Space Narrowing in Rheumatoid Arthritis
Rheumatoid Arthritis – Clinical Aspects Poster I: Treatment Patterns and Response- 9:00AM-11:00AM
-
Abstract Number: 19
The Transcription Factor Specificity Protein 1 up-Regulates IL-21 Receptor Expression on B Cells in Rheumatoid Arthritis Leading to Altered Cytokine Production and Maturation
B Cell Biology and Targets in Autoimmune Disease Poster- 9:00AM-11:00AM
-
Abstract Number: 271
The Trend of Incidence Rate, Frequency and HLA Phenotype of Reactive Arthritis and Uveitis in Japanese Patients with Bladder Cancer Following Intravesical BCG Therapy: A 20-Year, Two-Center Retrospective Study
Infection-related Rheumatic Disease Poster- 9:00AM-11:00AM
-
Abstract Number: 159
The Use of “Fibromyalgia Rapid Screening Tool” for Detection of Fibromyalgia in Patients with Chronic Arthritis Treated with Full and Tapered Biological Disease-Modifying Antirheumatic Drugs
Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes Poster I- 9:00AM-11:00AM
-
Abstract Number: 257
The Use of Positron Emission Tomography (PET)-Scan for the Quantitative Assessment of Interstitial Lung Disease in Systemic Sclerosis
Imaging of Rheumatic Diseases Poster I- 9:00AM-11:00AM
-
Abstract Number: 279
the Usefulness of Cytomegalovirus Infection Strategy in Patients with Connective-Tissue Disease, Based on the Guidelines of the Japan Society for Hematopoietic Cell Transplantation 2011
Infection-related Rheumatic Disease Poster- 9:00AM-11:00AM
-
Abstract Number: 693
The Utility of a Rise in Anti – Double Stranded DNA Antibodies for Predicting Disease Flares in Systemic Lupus Erythematosus. a Meta-Analysis
Systemic Lupus Erythematosus – Clinical Aspects and Treatment Poster I: Biomarkers and Outcomes